The Journal of thoracic and cardiovascular surgery
-
J. Thorac. Cardiovasc. Surg. · Aug 2023
Discussion to: Workforce diversity in cardiothoracic surgery: An examination of recent demographic changes and the training pathway.
The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://dx.doi.org/10.1016/j.jtcvs.2023.09.007. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal.
-
J. Thorac. Cardiovasc. Surg. · Aug 2023
Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society of Thoracic Surgeons Database.
To determine the relationship between volume of cases and failure-to-rescue (FTR) rate after surgery for acute type A aortic dissection (ATAAD) across the United States. ⋯ Although high-volume centers performed more complex procedures than low-volume centers, their operative mortality was lower, perhaps reflecting their ability to rescue patients and mitigate complications. An average of fewer than 10 cases per year at an institution is associated with increased odds of failure to rescue patients after ATAAD repair.
-
J. Thorac. Cardiovasc. Surg. · Aug 2023
Long-term survival and quality of life after extracorporeal membrane oxygenation.
Long-term data on patient survivors after extracorporeal membrane oxygenation (ECMO) support remains limited. This study sought to examine the 5-year survival and health-related quality of life (HRQoL) of patients treated with venoarterial (VA)- or venovenous (VV)-ECMO. ⋯ Five-year clinical and patient-centered outcomes of patients requiring ECMO support is acceptable in those who survived the initial 30 days. Among ECMO survivors, persistent HRQoL concerns were apparent, highlighting the importance of longer-term postdischarge follow-up.
-
J. Thorac. Cardiovasc. Surg. · Aug 2023
Randomized Controlled TrialOverestimation of screening-related complications in the National Lung Screening Trial.
Lung cancer screening-associated complications are often quoted as one of the major barriers for wider screening adoption. A detailed analysis of the National Lung Screening Trial dataset was performed to extrapolate the safety of lung cancer screening. ⋯ It is more informative to report procedural complications in patients not found to have cancer as the true screening-associated risk. Only 4 in 10,000 of patients undergoing low-dose computed tomography screening but not found to have lung cancer will have major complications. Permanent or debilitating complications are exceedingly rare.